Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Suspected non-AD pathology in mild cognitive impairment.

Wisse LE, Butala N, Das SR, Davatzikos C, Dickerson BC, Vaishnavi SN, Yushkevich PA, Wolk DA; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Dec;36(12):3152-62. doi: 10.1016/j.neurobiolaging.2015.08.029. Epub 2015 Sep 7.

PMID:
26422359
2.

Study of amyloid-β peptide functional brain networks in AD, MCI and HC.

Jiang J, Duan H, Huang Z, Yu Z; Alzheimer's Disease Neuroimaging Initiative.

Biomed Mater Eng. 2015;26 Suppl 1:S2197-205. doi: 10.3233/BME-151525.

PMID:
26405999
3.

Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.

Wang C, Tan L, Wang HF, Yu WJ, Liu Y, Jiang T, Tan MS, Hao XK, Zhang DQ, Yu JT; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;46(2):491-5. doi: 10.3233/JAD-150110.

PMID:
26402410
4.

Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.

Zhan Y, Chen K, Wu X, Zhang D, Zhang J, Yao L, Guo X; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(4):1057-67. doi: 10.3233/JAD-142820.

PMID:
26401783
5.

Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.

Malpas CB, Saling MM, Velakoulis D, Desmond P, O'Brien TJ; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(4):965-75. doi: 10.3233/JAD-142643.

PMID:
26401775
6.

Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study.

Klöppel S, Peter J, Ludl A, Pilatus A, Maier S, Mader I, Heimbach B, Frings L, Egger K, Dukart J, Schroeter ML, Perneczky R, Häussermann P, Vach W, Urbach H, Teipel S, Hüll M, Abdulkadir A; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(4):939-54. doi: 10.3233/JAD-150334.

PMID:
26401773
7.

Risk Stratification Using Cerebrospinal Fluid Biomarkers in Patients with Mild Cognitive Impairment: An Exploratory Analysis.

Michaud TL, Kane RL, McCarten JR, Gaugler JE, Nyman JA, Kuntz KM; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(3):729-40. doi: 10.3233/JAD-150066.

PMID:
26401707
8.

Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.

Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.

BMC Geriatr. 2015 Sep 7;15:107. doi: 10.1186/s12877-015-0103-3.

9.

Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution.

Chiang GC, Cruz Hernandez JC, Kantarci K, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2015 Sep;36(9):1635-41. doi: 10.3174/ajnr.A4351. Epub 2015 Jul 30.

PMID:
26228889
10.

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.

Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, Moghekar A, Albert M, Hu WT, Monge Argilés JA, Gorostidi A, Teunissen CE, De Deyn PP, Hyman BT, Molinuevo JL, Frisoni GB, Linazasoro G, de Leon MJ, van der Flier WM, Scheltens P, Blennow K, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2015 Sep;138(Pt 9):2701-15. doi: 10.1093/brain/awv199. Epub 2015 Jul 27.

PMID:
26220940
11.

Associations between Verbal Learning Slope and Neuroimaging Markers across the Cognitive Aging Spectrum.

Gifford KA, Phillips JS, Samuels LR, Lane EM, Bell SP, Liu D, Hohman TJ, Romano RR 3rd, Fritzsche LR, Lu Z, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2015 Jul;21(6):455-67. doi: 10.1017/S1355617715000430.

12.

Estimating anatomical trajectories with Bayesian mixed-effects modeling.

Ziegler G, Penny WD, Ridgway GR, Ourselin S, Friston KJ; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Nov 1;121:51-68. doi: 10.1016/j.neuroimage.2015.06.094. Epub 2015 Jul 17.

13.

Longitudinal Partial Volume Correction in 2-[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Studies of Alzheimer Disease.

Malpas CB, Saling MM, Velakoulis D, Desmond P, Hicks RJ, OʼBrien TJ; Alzheimer Disease Neuroimaging Initiative.

J Comput Assist Tomogr. 2015 Jul-Aug;39(4):559-64. doi: 10.1097/RCT.0000000000000256.

PMID:
26182225
14.

A FDG-PET Study of Metabolic Networks in Apolipoprotein E ε4 Allele Carriers.

Yao Z, Hu B, Zheng J, Zheng W, Chen X, Gao X, Xie Y, Fang L; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2015 Jul 10;10(7):e0132300. doi: 10.1371/journal.pone.0132300. eCollection 2015.

15.

Rich club analysis in the Alzheimer's disease connectome reveals a relatively undisturbed structural core network.

Daianu M, Jahanshad N, Nir TM, Jack CR Jr, Weiner MW, Bernstein MA, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2015 Aug;36(8):3087-103. doi: 10.1002/hbm.22830. Epub 2015 Jun 3.

PMID:
26037224
16.

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.

Ayton S, Faux NG, Bush AI; Alzheimer's Disease Neuroimaging Initiative.

Nat Commun. 2015 May 19;6:6760. doi: 10.1038/ncomms7760.

17.

Regional flux analysis for discovering and quantifying anatomical changes: An application to the brain morphometry in Alzheimer's disease.

Lorenzi M, Ayache N, Pennec X; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neuroimage. 2015 Jul 15;115:224-34. doi: 10.1016/j.neuroimage.2015.04.051. Epub 2015 May 8.

PMID:
25963734
18.

A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI.

Iglesias JE, Augustinack JC, Nguyen K, Player CM, Player A, Wright M, Roy N, Frosch MP, McKee AC, Wald LL, Fischl B, Van Leemput K; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Jul 15;115:117-37. doi: 10.1016/j.neuroimage.2015.04.042. Epub 2015 Apr 29.

19.

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease.

Li R, Perneczky R, Yakushev I, Förster S, Kurz A, Drzezga A, Kramer S; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2015 Apr 28;10(4):e0122731. doi: 10.1371/journal.pone.0122731. eCollection 2014.

20.

Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.

Savage MJ, Holder DJ, Wu G, Kaplow J, Siuciak JA, Potter WZ; Foundation for National Institutes of Health (FNIH) Biomarkers Consortium CSF Proteomics Project Team for Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;46(2):431-40. doi: 10.3233/JAD-142778.

PMID:
25790831
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk